--ATN International Keeps Quarterly Dividend at $0.24 Per Share, Payable on April 5 to Shareholders of Record on March 31-February 2024-www.financetom.com

--ATN International Keeps Quarterly Dividend at $0.24 Per Share, Payable on April 5 to Shareholders of Record on March 31

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--ATN International Keeps Quarterly Dividend at $0.24 Per Share, Payable on April 5 to Shareholders of Record on March 31

Mar 18, 2024 11:38 AM

02:13 PM EDT, 03/18/2024 (MT Newswires) --

Price: 31.12, Change: -0.57, Percent Change: -1.80

Previous page： --Street Color: Advanced Micro Devices Reportedly Cutting About 4% of Global Workforce Next page： Frontier Communications Shareholders Approve Acquisition by Verizon

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Street Color: Advanced Micro Devices Reportedly Cutting About 4% of Global Workforce

Nov 13, 2024

10:56 AM EST, 11/13/2024 (MT Newswires) -- Price: 142.13, Change: -1.50, Percent Change: -1.04 ...

Frontier Communications Shareholders Approve Acquisition by Verizon

Nov 13, 2024

10:51 AM EST, 11/13/2024 (MT Newswires) -- Frontier Communications Parent ( FYBR ) said Wednesday its shareholders have approved Verizon Communications' ( VZ ) acquisition of the company in a deal valued at $20 billion. The acquisition is expected to be completed in Q1 2026, subject to regulatory approvals, the company said. Frontier shares were up about 2.3%, while Verizon...

Microvast Stock Is Soaring Wednesday: Here's Why

Nov 13, 2024

Microvast Holdings Inc ( MVST ) shares are soaring Wednesday morning on the heels of the company’s third-quarter financial results. Here’s what you need to know. What To Know: Microvast ( MVST ) reported third-quarter revenue of $101.4 million, beating analyst estimates of $99.7 million, according to Benzinga Pro. The company reported third-quarter adjusted earnings of 5 cents per share,...

Creative Medical Gets Safety Approval in FDA-Cleared Back Pain Treatment Trial

Nov 13, 2024

11:03 AM EST, 11/13/2024 (MT Newswires) -- Creative Medical Technology ( CELZ ) said Wednesday its experimental treatment for chronic lower back pain due to degenerative disc disease, CELZ-201, successfully passed an independent interim safety review by the Data Safety Monitoring Board in its clinical trial. The clearance to proceed with the ADAPT clinical trial, which will evaluate the safety,...